1
|
Shyp T, Mousavizadeh R, Negri GL, Zhang HF, Lizardo M, Sorensen P. Abstract B013: STEAP1 facilitates iron transport in ewing sarcoma to support mitochondrial activity. Clin Cancer Res 2022. [DOI: 10.1158/1557-3265.sarcomas22-b013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Ewing sarcoma (EwS) is a highly aggressive bone-associated tumor of children and young adults with strong propensity to progress and dismal outcome for patients with advanced stages of the disease. EwS is defined by a pathognomonic recurrent potent transcription factor, in 85-90% of cases EWSR1-FLI1. One of the previously described transcriptional targets of EWSR1-FLI1 is six-transmembrane epithelial antigen of the prostate 1 (STEAP1). STEAP1 is a member of the STEAP membrane-bound protein family involved in reduction of iron and copper which is a crucial step for metal transport and overexpressed in various malignancies. However, a precise functional role of STEAP1 in cancers including EwS remains elusive. EwS cell lines with knockout (KO) or knockdown (KD) of STEAP1 were created to perform functional studies for elucidating the functions of STEAP1 in EwS, including transient metal measurements. Additionally, the measurement of functional mitochondrial activity was performed by an extracellular flux analyzer. The activity of the mitochondrial electron transport chain complexes was measured by blue native PAGE. We showed that STEAP1 functions as a metalloreductase and STEAP1 KO cells have lower intracellular iron levels. Furthermore, we discovered that STEAP1 KO cells have significantly lower levels of the mitochondrial labile iron pool. Consequently, EwS cells with STEAP1 KO demonstrated impaired mitochondrial respiration and increased glycolysis rates. Additionally, the functional activity of iron-sulfur containing proteins and the the assembly of subunits of the mitochondrial electron transport chain complexes were decreased. This study is the first to demonstrate in vitro involvement of STEAP1 in transitional metal homeostasis and mitochondrial activity. These discoveries unveil alternative therapeutic strategies for EwS patients such as using compounds that promote an iron-dependent form of cell death, ferroptosis, or drugs that decrease metabolic adaptability.
Citation Format: Taras Shyp, Rouhollah Mousavizadeh, Gian Luca Negri, Hai-Feng Zhang, Michael Lizardo, Poul Sorensen. STEAP1 facilitates iron transport in ewing sarcoma to support mitochondrial activity [abstract]. In: Proceedings of the AACR Special Conference: Sarcomas; 2022 May 9-12; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2022;28(18_Suppl):Abstract nr B013.
Collapse
Affiliation(s)
- Taras Shyp
- 1BC Cancer Research Institute, Vancouver, BC, Canada,
| | | | - Gian Luca Negri
- 3Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
| | | | | | - Poul Sorensen
- 1BC Cancer Research Institute, Vancouver, BC, Canada,
| |
Collapse
|
2
|
Zhang HF, El-Naggar AM, Cheng H, Prudova A, Delaidelli A, He JZ, Negri GL, Lizardo M, Yang T, Morin G, Li W, Dimitrov DS, Sorensen PH. Abstract 6080: IL1RAP augments Cysteine metabolism and drives oxidative stress adaptation and lung metastasis in Ewing sarcoma. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-6080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The high oxidative stress cancer cells experience during the metastatic cascade is an important determinant of metastasis. How cancer cells adapt to those stressful conditions remains elusive. Here our global translatome and proteome analyses have uncovered novel signatures exploited by oncogene-transformed cells to adapt and survive oxidative stress. We revealed that various oncoproteins promote the expression of the IL1RAP to alleviate oxidative stress and facilitate stress adaptation. Mechanistically, IL1RAP controls Cysteine metabolism, a key substrate and determinant of antioxidant glutathione synthesis. CTH, a crucial enzyme for de novo Cysteine synthesis and redox regulation, was identified as a key functional mediator of IL1RAP. Moreover, global interactome analysis uncovered IL1RAP as a novel component and enhancer of the System Xc− transporter (SLC7A11), which is involved in Cystine uptake. Thus, IL1RAP enhances Cysteine supply via both uptake and biogenesis. IL1RAP depletion rendered Ewing sarcoma cells susceptible to oxidative stress and ferroptosis in vitro, and dramatically mitigated local invasion and lung metastasis in mice. In patients with Ewing sarcoma, high-expression of IL1RAP in the tumors correlated with poor event-free survival. Therefore, we have defined a novel pro-metastatic mechanism driven by IL1RAP-mediated Cysteine metabolism and redox regulation.
Citation Format: Hai-Feng Zhang, Amal M. El-Naggar, Hongwei Cheng, Anna Prudova, Alberto Delaidelli, Jian-Zhong He, Gian Luca Negri, Michael Lizardo, Tianqing Yang, Gregg Morin, Wei Li, Dimiter S. Dimitrov, Poul H. Sorensen. IL1RAP augments Cysteine metabolism and drives oxidative stress adaptation and lung metastasis in Ewing sarcoma [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 6080.
Collapse
Affiliation(s)
- Hai-Feng Zhang
- 1University of British Columbia, Vancouver, British Columbia, Canada
| | - Amal M. El-Naggar
- 1University of British Columbia, Vancouver, British Columbia, Canada
| | | | - Anna Prudova
- 1University of British Columbia, Vancouver, British Columbia, Canada
| | | | | | | | | | - Tianqing Yang
- 1University of British Columbia, Vancouver, British Columbia, Canada
| | - Gregg Morin
- 2BC Cancer, Vancouver, British Columbia, Canada
| | - Wei Li
- 4University of Pittsburgh, Pittsburgh, PA
| | | | - Poul H. Sorensen
- 1University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
3
|
Vislovukh A, Hughes C, Lizardo M, Sorensen PH. Abstract B55: MYCN promotes m6a-dependent translation of eEF2K mRNA during adaptation to ER stress. Cancer Res 2020. [DOI: 10.1158/1538-7445.pedca19-b55] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
MYCN-amplified neuroblastoma is one of the most common and malignant pediatric tumors with low survival rates. Attempts to develop specific inhibitors to target MYCN have not been successful, prioritizing research into MYCN downstream targets. It was previously shown that eukaryotic translation elongation factor 2 (eEF2K) is upregulated in MYCN-amplified neuroblastoma and facilitates its adaptation to the nutrient deprivation (ND). However, the mechanism of eEF2K overexpression and its role in such adaptation is unknown. Using SUnSET assays, we showed that MYCN overexpression increases protein synthesis rates, demonstrating that MYCN-amplified cells depend on protein biosynthesis to cover the needs of fast proliferation. Enhanced protein biosynthesis increases the susceptibility for protein aggregates and subsequent unfolded protein response (UPR) activation and ER stress. ER stress also occurs under ND due to accumulation of unglycosylated proteins in the ER. To check how MYCN-amplified tumors might adapt to ER stress, we performed gene set enrichment analyses (GSEA) of genes that are overexpressed in MYCN amplified neuroblastoma and found “UPR” in the top 10 gene sets. As eEF2K regulates protein synthesis rates by slowing down the elongation step of mRNA translation, we examined whether eEF2K is part of the ER stress adaptation mechanism in MYCN-amplified cells. We found that during ND, eEF2K KO cells are more sensitive to thapsigargin (Tg) and tunicamycin (Tm), ER stress-inducing compounds, and show higher levels of ATF4, a major ER stress marker. Notably, low doses of cycloheximide, which blocks translation elongation, rescued the phenotype in eEF2K KO cells, confirming that the observed effect of eEF2K KO is linked to translation elongation. Finally, GSEA of RNAseq data obtained from TET21N WT vs. eEF2K KO after ND showed upregulation of genes responsible for the UPR and ER stress in eEF2K KO cells. Therefore, eEF2K appears to be linked to ER stress adaptation. To find potential mechanisms of MYCN-dependent regulation of eEF2K expression, we performed bioinformatic analyses of the eEF2K mRNA and found potential binding sites for METTL3, an enzyme that functions in the methylation of adenosine residues in mRNAs, in the eEF2K 3´-UTR. METTL3 knockdown resulted in a marked decrease of eEF2K protein without significant changes at the mRNA level. We applied polysome fractionation to study the effect of m6a modification on eEF2K mRNA translation. We discovered that METTL3 KD brings eEF2K mRNA to lighter polysome fractions compared with WT cells. As YTHDF1 is the only known reader of m6a modification that increases translation, we performed YTHDF1 knockdown and observed a decrease in eEF2K protein levels. Our findings indicate that MYCN amplified neuroblastoma cells increase translation of eEF2K mRNAs via a METTL3-YTHDF1 axis, and that this potentially functions as part of an adaptation mechanism under increased protein synthesis and subsequent ER stress.
Citation Format: Andrii Vislovukh, Cristopher Hughes, Michael Lizardo, Poul H. Sorensen. MYCN promotes m6a-dependent translation of eEF2K mRNA during adaptation to ER stress [abstract]. In: Proceedings of the AACR Special Conference on the Advances in Pediatric Cancer Research; 2019 Sep 17-20; Montreal, QC, Canada. Philadelphia (PA): AACR; Cancer Res 2020;80(14 Suppl):Abstract nr B55.
Collapse
Affiliation(s)
- Andrii Vislovukh
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
| | - Cristopher Hughes
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
| | - Michael Lizardo
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
| | - Poul H. Sorensen
- Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, BC, Canada
| |
Collapse
|
4
|
Langman S, Lizardo M, Forget A, Ayrault O, Sorensen P. MEDU-42. ELUCIDATING THE ROLE OF STRESS GRANULE FORMATION IN MEDULLOBLASTOMA. Neuro Oncol 2019. [DOI: 10.1093/neuonc/noz036.200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Sofya Langman
- University of British Columbia, Vancouver, BC, Canada
| | | | | | | | - Poul Sorensen
- University of British Columbia, Vancouver, BC, Canada
| |
Collapse
|
5
|
Ren L, Hong ES, Mendoza A, Issaq S, Tran Hoang C, Lizardo M, LeBlanc A, Khanna C. Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. Oncotarget 2018; 8:38541-38553. [PMID: 28404949 PMCID: PMC5503552 DOI: 10.18632/oncotarget.15872] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Accepted: 01/27/2017] [Indexed: 11/25/2022] Open
Abstract
Cancer development and progression are characterized by complex molecular events. The acquisition of these events is primarily believed to result from alterations in gene and protein expression/function. Recent studies have also suggested the role of metabolic alterations, or "metabolic reprogramming," that may similarly contribute to these events. Indeed, our previous investigations in osteosarcoma (OS) identified metabolic changes uniquely linked to metastasis. Based on those findings, here we sought to build a more detailed understanding of the specific alterations in metabolites or metabolic pathways that may be responsible for the observed metastasis-associated metabolic alterations, suggested by gene expression data. This was pursued using a combination of high-throughput liquid- and gas-chromatography-based mass spectrometry (LC/MS and GC/MS) for a global metabolic profiling/subtraction of four pairs of high/low metastatic OS cell lines. By comparing the identity and level of the metabolites between high/low metastatic cells, several metabolic pathways were identified to be differentially activated, such as arginine, glutathione, inositol and fatty acid metabolic pathways. To further interrogate these results, we investigated the effects of inositol pathway dysregulation, through the exposure of metastatic OS cells to IP6 (inositol hexaphosphate). Although IP6 exposures had modest to minimal effects on cell proliferation, we observed reduced cellular glycolysis, down-regulation of PI3K/Akt signaling and suppression of OS metastatic progression. Collectively these data supported further investigation of metabolic sensitivities as anti-metastatic strategies in a clinical setting as well as investigation of altered metabolomics associated with metastatic progression.
Collapse
Affiliation(s)
- Ling Ren
- Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Ellen S Hong
- Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Arnulfo Mendoza
- Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Sameer Issaq
- Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Christine Tran Hoang
- Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Michael Lizardo
- Molecular Oncology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Amy LeBlanc
- Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
| | - Chand Khanna
- Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.,Dr. Khanna is currently with Ethos Veterinary Health, Woburn MA and Ethos Discovery, Washington DC, USA
| |
Collapse
|
6
|
Yan HH, Jiang J, Pang Y, Achyut BR, Lizardo M, Liang X, Hunter K, Khanna C, Hollander C, Yang L. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ. Cancer Res 2015; 75:5283-98. [PMID: 26483204 DOI: 10.1158/0008-5472.can-15-2282-t] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2015] [Accepted: 09/07/2015] [Indexed: 01/06/2023]
Abstract
Tumor cell survival in the hostile distant organ is a rate-limiting step in cancer metastasis. Bone marrow-derived myeloid cells can form a premetastatic niche and provide a tumor-promoting microenvironment. However, it is unclear whether these myeloid cells in the premetastatic site have any direct effect on tumor cell survival. Here, we report that chemokine CCL9 was highly induced in Gr-1(+)CD11b(+) immature myeloid cells and in premetastatic lung in tumor-bearing mice. Knockdown of CCL9 in myeloid cells decreased tumor cell survival and metastasis. Importantly, CCL9 overexpression in myeloid cells lacking TGFβ signaling rescued the tumor metastasis defect observed in mice with myeloid-specific Tgfbr2 deletion. The expression level of CCL23, the human orthologue for CCL9, in peripheral blood mononuclear cells correlated with progression and survival of cancer patients. Our study demonstrates that CCL9 could serve as a good candidate for anti-metastasis treatment by targeting the rate-limiting step of cancer cell survival. In addition, targeting CCL9 may avoid the adverse effects of TGFβ-targeted therapy.
Collapse
Affiliation(s)
- Hangyi H Yan
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
| | - Jian Jiang
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Chengdu, Sichuan, P.R. China
| | - Yanli Pang
- Department of Physiology & Pathophysiology, Peking University Health Science Center, Beijing, P.R. China
| | - B R Achyut
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
| | - Michael Lizardo
- Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland
| | - Xinhua Liang
- State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Chengdu, Sichuan, P.R. China
| | - Kent Hunter
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
| | - Chand Khanna
- Pediatric Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland
| | - Christine Hollander
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
| | - Li Yang
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.
| |
Collapse
|
7
|
Webb M, Emberley ED, Lizardo M, Alowami S, Qing G, Alfia'ar A, Snell-Curtis LJ, Niu Y, Civetta A, Myal Y, Shiu R, Murphy LC, Watson PH. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer 2005; 5:17. [PMID: 15717926 PMCID: PMC553966 DOI: 10.1186/1471-2407-5-17] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2004] [Accepted: 02/17/2005] [Indexed: 11/10/2022] Open
Abstract
Background The human psoriasin (S100A7) gene has been implicated in inflammation and tumor progression. Implementation of a mouse model would facilitate further investigation of its function, however little is known of the murine psoriasin gene. In this study we have cloned the cDNA and characterized the expression of the potential murine ortholog of human S100A7/psoriasin in skin inflammation and mammary tumorigenesis. Methods On the basis of chromosomal location, phylogenetic analysis, amino acid sequence similarity, conservation of a putative Jab1-binding motif, and similarities of the patterns of mouse S100A7/psoriasin gene expression (measured by RT-PCR and in-situ hybridization) with those of human S100A7/psoriasin, we propose that mouse S100A7/psoriasin is the murine ortholog of human psoriasin/S100A7. Results Although mouse S100A7/psoriasin is poorly conserved relative to other S100 family members, its pattern of expression parallels that of the human psoriasin gene. In murine skin S100A7/psoriasin was significantly upregulated in relation to inflammation. In murine mammary gland expression is also upregulated in mammary tumors, where it is localized to areas of squamous differentiation. This mirrors the context of expression in human tumor types where both squamous and glandular differentiation occur, including cervical and lung carcinomas. Additionally, mouse S100A7/psoriasin possesses a putative Jab1 binding motif that mediates many downstream functions of the human S100A7 gene. Conclusion These observations and results support the hypothesis that the mouse S100A7 gene is structurally and functionally similar to human S100A7 and may offer a relevant model system for studying its normal biological function and putative role in tumor progression.
Collapse
Affiliation(s)
- Meghan Webb
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
| | - Ethan D Emberley
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Canada
| | | | - Salem Alowami
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
| | - Gefei Qing
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
| | | | - Linda J Snell-Curtis
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
| | - Yulian Niu
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
| | - Alberto Civetta
- Dept of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Canada
- Dept of Biology, University of Winnipeg, Winnipeg, Canada
| | - Yvonne Myal
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
| | - Robert Shiu
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Physiology, University of Manitoba, Winnipeg, Canada
| | - Leigh C Murphy
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Canada
| | - Peter H Watson
- Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada
- Dept of Pathology, University of Manitoba, Winnipeg, Canada
- Dept of Biochemistry & Medical Genetics, University of Manitoba, Winnipeg, Canada
| |
Collapse
|
8
|
Qi K, Qiu H, Sun D, Minuk GY, Lizardo M, Rutherford J, Orr FW. Impact of cirrhosis on the development of experimental hepatic metastases by B16F1 melanoma cells in C57BL/6 mice. Hepatology 2004; 40:1144-50. [PMID: 15382152 DOI: 10.1002/hep.20421] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Metastases rarely occur in human livers with cirrhosis in clinical studies. We postulated that this phenomenon would also occur in experimental cirrhosis. Cirrhosis was established in C57BL/6 mice by carbon tetrachloride (CCl(4)) gastrogavage. B16F1 melanoma cells were injected into the mesenteric vein to induce hepatic metastases. Contrary to our postulate, there was greater than 4-fold increase in metastasis in animals with cirrhosis compared to controls. Intravital videomicroscopy showed that the hepatic sinusoids were narrower and more tumor cells were retained in the terminal portal vein (TPV) in cirrhotic livers. Immunohistochemistry demonstrated that the expression of vascular adhesion molecules was significantly increased in cirrhosis. Using confocal microscopy and the fluorescent nitric oxide (NO) probe 4,5-diaminofluorescein diacetate, a significantly lower level of NO release was detected in livers with cirrhosis both in basal conditions and after tumor cell arrest. Eight hours after mesenteric vein tumor cell injection, the percentage of apoptotic tumor cells in the sinusoids was 17% +/- 2% in livers with cirrhosis and 30% +/- 5% in normal livers. More mitotic and Ki-67 labeled tumor cells were seen in livers with cirrhosis. In conclusion, the changes in architecture and adhesion molecule expression in livers with cirrhosis may cause more tumor cells to arrest in the TPV. Lower levels of NO production may reduce apoptosis of B16F1 cells in livers with cirrhosis. As a result, these changes may promote the growth of metastasis in this cirrhotic model.
Collapse
MESH Headings
- Animals
- Apoptosis
- Cell Division
- Cell Line, Tumor
- Female
- Fluorescein
- Immunohistochemistry
- Indicators and Reagents
- Liver/pathology
- Liver Cirrhosis, Experimental/complications
- Liver Cirrhosis, Experimental/metabolism
- Liver Cirrhosis, Experimental/pathology
- Liver Neoplasms/complications
- Liver Neoplasms/pathology
- Liver Neoplasms/physiopathology
- Liver Neoplasms/secondary
- Melanoma, Experimental/complications
- Melanoma, Experimental/pathology
- Melanoma, Experimental/physiopathology
- Melanoma, Experimental/secondary
- Mice
- Mice, Inbred C57BL
- Microscopy, Confocal
- Microscopy, Video
- Nitric Oxide/metabolism
- Vascular Cell Adhesion Molecule-1/metabolism
Collapse
Affiliation(s)
- Ke Qi
- Department of Pathology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada R3E 0W3
| | | | | | | | | | | | | |
Collapse
|